Cargando…

Combined Treatment with Anticancer Vaccine Using Genetically Modified Endothelial Cells and Imatinib in Bladder Cancer

PURPOSE: We sought to maximize the antitumor effect of an anticancer vaccine based on genetically modified endothelial cells by combining it with the platelet-derived growth factor receptor inhibitor imatinib. MATERIALS AND METHODS: Human umbilical vein endothelial cells (HUVECs) were infected with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Seung Beom, Park, Yong Hyun, Lee, Eunhye, Ku, Ja Hyeon, Kim, Hyeon Hoe, Kwak, Cheol
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106165/ https://www.ncbi.nlm.nih.gov/pubmed/21687392 http://dx.doi.org/10.4111/kju.2011.52.5.327

Ejemplares similares

Prognostic Role of Survivin in Bladder Cancer: A Systematic Review and Meta-Analysis
por: Jeon, Chanhoo, et al.
Publicado: (2013)

Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor
por: Kang, Minyong, et al.
Publicado: (2016)

Stratifying risk for multiple, recurrent, and large (≥3 cm) Ta, G1/G2 tumors in non-muscle-invasive bladder cancer
por: Suh, Jungyo, et al.
Publicado: (2021)

Prognostic Significance of Lymphovascular Invasion in Radical Cystectomy on Patients with Bladder Cancer: A Systematic Review and Meta-Analysis
por: Kim, Hwanik, et al.
Publicado: (2014)

Clinical determinants of recurrence in pTa bladder cancer following transurethral resection of bladder tumor
por: Jeong, Seung-hwan, et al.
Publicado: (2022)

Inhibition of Autophagy Potentiates Atorvastatin-Induced Apoptotic Cell Death in Human Bladder Cancer Cells in Vitro
por: Kang, Minyong, et al.
Publicado: (2014)

The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision
por: Kang, Minyong, et al.
Publicado: (2015)

Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?
por: Yuk, Hyeong Dong, et al.
Publicado: (2018)

Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Non-muscle Invasive Bladder Cancer Patients: Initial Intravesical Bacillus Calmette-Guerin Treatment After Transurethral Resection of Bladder Tumor Setting
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis
por: Ko, Kyungtae, et al.
Publicado: (2017)

Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer
por: Tae, Bum Sik, et al.
Publicado: (2017)

Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials
por: Kim, Hyung Suk, et al.
Publicado: (2017)

Next-Generation Proteomics–Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis
por: Suh, Jungyo, et al.
Publicado: (2022)

External Validation of Models for Prediction of Lymph Node Metastasis in Urothelial Carcinoma of the Bladder
por: Ku, Ja Hyeon, et al.
Publicado: (2015)

Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs
por: Kang, Minyong, et al.
Publicado: (2016)

Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study
por: Kim, Myong, et al.
Publicado: (2015)

Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis
por: Ku, Ja Hyeon, et al.
Publicado: (2015)

Pyuria as a Predictive Marker of Bacillus Calmette–Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer
por: Suh, Jungyo, et al.
Publicado: (2021)

De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study
por: Yuk, Hyeong Dong, et al.
Publicado: (2019)

Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder
por: Kim, Hyung Suk, et al.
Publicado: (2015)

Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor
por: Kim, Byung Soo, et al.
Publicado: (2018)

Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy
por: Park, Yong Hyun, et al.
Publicado: (2014)

Extramammary Paget Disease of External Genitalia: Surgical Excision and Follow-up Experiences With 19 Patients
por: Jung, Jae Hyun, et al.
Publicado: (2013)

Dose, duration and strain of bacillus Calmette–Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials
por: Quan, Yongjun, et al.
Publicado: (2017)

The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy
por: Lee, Joong Sub, et al.
Publicado: (2015)

Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort of Korean Patients
por: Kim, Hyung Suk, et al.
Publicado: (2015)

Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis
por: Oh, Jong Jin, et al.
Publicado: (2019)

Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells
por: Lee, Kyoung-Hwa, et al.
Publicado: (2020)

Psychometric validation study of the Korean version of the Functional Assessment of Cancer Therapy-Vanderbilt Cystectomy Index
por: Kim, Myong, et al.
Publicado: (2018)

Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group
por: Yuk, Hyeong Dong, et al.
Publicado: (2018)

Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells
por: Kang, Minyong, et al.
Publicado: (2017)

Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
por: Tae, Bum Sik, et al.
Publicado: (2017)

Significance of Predicted Tumor Volume as a Predictor of Pathologic Stage in Patients Undergoing Radical Prostatectomy
por: Ku, Ja Hyeon, et al.
Publicado: (2011)

Surgical Clip-Related Complications after Radical Prostatectomy
por: Yi, Jun Seok, et al.
Publicado: (2010)

Impact of Prostate Size on Pathologic Outcomes and Prognosis after Radical Prostatectomy
por: Min, Sun Ho, et al.
Publicado: (2012)

Adjuvant Chemotherapy Correlates with Improved Survival after Radical Cystectomy in Patients with pT3b (Macroscopic Perivesical Tissue Invasion) Bladder Cancer
por: Kim, Hyung Suk, et al.
Publicado: (2015)

MLL5, a histone modifying enzyme, regulates androgen receptor activity in prostate cancer cells by recruiting co-regulators, HCF1 and SET1
por: Lee, Kyoung-Hwa, et al.
Publicado: (2020)

Second-Line Systemic Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials
por: Yoon, Hyun Sik, et al.
Publicado: (2019)

Prognostic factors for conditional survival in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy
por: Kang, Minyong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mr3g9lrltoj62aso17obbq2ocd